Director/Sr. Director, Patient Advocacy

About MLBio Solutions & BridgeBio Pharma

ML Bio Solutions (ML Bio), a BridgeBio company, is a biotechnology company founded in 2018, yet the company’s founders have been dedicated to finding a cure for Limb girdle muscular dystrophy type 2I/R9 FKRP-related (LGMD2I/LGMDR9) for close to twenty years. ML Bio is developing BBP-418, potentially the first oral treatment for patients with LGMD2I.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas, including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.  
 
Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 
 
To learn more about our story and company culture, visit us at https://mlbiosolutions.com/ | https://bridgebio.com

Who You Are

The Director/Sr. Director, Patient Advocacy will lead the global patient advocacy function at ML Bio, reporting to the Chief Medical Officer. The Director will be responsible for shaping and implementing the global advocacy and engagement strategy at ML Bio and will ensure productive and enduring relationships with patient advocacy organizations supporting individuals living with LGMD2I/R9 and other alpha-dystroglycanopathies. The individual will align the advocacy strategy with the Medical Affairs/scientific platform and corporate strategies, lead global outreach to patient advocacy groups, and educate and support internal teams, ensuring they are aware of the needs and experiences of patients. The ideal candidate should thrive in a high-energy, dynamic work environment, be able to work both independently and collaboratively and maintain focus on the needs of patients and families. This is a critical role to the team because BridgeBio ultimately exists to help patients, and “putting patients first” is a core value.

Responsibilities

• Maintain the highest level of ethics. Act with honesty, integrity, and transparency in collaboration with patients, families, and patient organizations
• Inspire a patients first mentality by communicating the “voice of the patient/caregiver” to internal teams and incorporating patient stories, imagery, and unmet needs in company activities and materials
• Develop and execute global patient advocacy strategy for the late clinical stage LGMD2I/R9 program at ML Bio Solutions, as well as development in other alpha-dystroglycanopathies by collaborating with internal teams that include clinical development, clinical operations, medical affairs, patient safety, legal, compliance, communications, commercial/marketing, and corporate development
• Conduct patient advisory boards and other activities to listen to the needs, experience, and opinions of patients and their family members at appropriate stages of clinical development
• Contribute to the organizational strategic planning process by providing patient and patient advocacy perspectives and sharing insights gleaned from interactions with those groups
• Display a thorough understanding of the latest compliance, legal, regulatory, and related matters affecting the biopharmaceutical sector regarding patient engagement, e.g., uphold confidentiality regarding sensitive scientific data and HIPAA-protected or GDRP-protected patient information
• Initiate and oversee the medical, legal, and regulatory review process for all advocacy communications and materials
• Oversee the advocacy budget and coordinate associated responsibilities, including managing grant and sponsorship requests by Patient Advocacy organizations

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who